Association of eNOS Glu298Asp gene polymorphism with circadian blood pressure rhythm.
Hypertensive patients with altered circadian blood pressure (BP) profile experience greater repercussion of hypertension on target organs and a higher risk of cardiovascular events, compared with those with physiological variations in BP. It has been demonstrated in animal models, that circadian variations in BP depend on several regulatory systems, in particular the nitric oxide-cGMP pathway. eNOS298 Glu/Asp polymorphism is a functional variant and may alter the amount of NO generated or eNOS activity. The objective of the present study was to find out whether eNOS298 gene polymorphism affects circadian BP regulation in 110 healthy subjects and 155 never-treated hypertensive patients recruited at Hypertension Units in Grenoble, Toulouse and Lille (France).
Ormezzano
O
O
Amar
J
J
Mounier Vehier
C
C
Cambien
F
F
Poirier
O
O
Chamontin
B
B
François
P
P
Mallion
J-M
JM
Baguet
J-P
JP
D000328:Adult; D000368:Aged; D001224:Aspartic Acid / Q000235:genetics; D001794:Blood Pressure / Q000235:genetics*; D002940:Circadian Rhythm / Q000235:genetics*; D018698:Glutamic Acid / Q000235:genetics; D006801:Humans; D006973:Hypertension / Q000235:genetics*; D008875:Middle Aged; D052250:Nitric Oxide Synthase Type III / Q000235:genetics*; D011110:Polymorphism, Genetic
D001224:Aspartic Acid; D018698:Glutamic Acid; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III